Brief: Pharmacyte Biotech Updates Status Of Investigational New Drug Application To FDA

Pharmacyte Biotech

14/02/2022 14:03

Feb 14 (Reuters) - PharmaCyte Biotech Inc  PMCB.O :
    * PHARMACYTE BIOTECH UPDATES STATUS OF INVESTIGATIONAL NEW
DRUG
APPLICATION TO FDA
    * PHARMACYTE BIOTECH INC - FDA REQUESTED ADDITIONAL STUDIES
AND
INFORMATION AS A PREREQUISITE FOR APPROVAL OF PHARMACYTE'S IND.
    * PHARMACYTE BIOTECH INC - NUMBER OF ADDITIONAL STUDIES AND
ASSAYS
HAVE ALREADY BEEN COMPLETED; SEVERAL OTHERS ARE UNDERWAY OR ARE
SLATED TO BEGIN SOON
    * PHARMACYTE BIOTECH INC - AS EACH STUDY AND ASSAY IS
COMPLETED,
RESULTS ARE BEING COMPILED AND WILL MAKE UP COMPLETE IND
SUBMISSION PACKAGE TO FDA
    * PHARMACYTE BIOTECH INC - PROVIDED UPDATE ON ACTIVITIES TO
LIFT
FDA'S CLINICAL HOLD ON TREATMENT FOR LOCALLY ADVANCED,
INOPERABLE PANCREATIC CANCER
    * PHARMACYTE BIOTECH - CO, SERVICE PROVIDERS UNDER SAME
CONSTRAINTS AS OTHERS GLOBALLY WITH SUPPLY CHAIN ISSUES, COVID
RELATED DELAYS, LATE DELIVERY OF MATERIALS

Source text for Eikon:  ID:nBw1fRY5La 
Further company coverage:  PMCB.O 

 ((Reuters.Briefs@thomsonreuters.com;))